YU23099A - Pharmaceutical compositions containing n-sulphonyl indolin derivatives - Google Patents

Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Info

Publication number
YU23099A
YU23099A YU23099A YU23099A YU23099A YU 23099 A YU23099 A YU 23099A YU 23099 A YU23099 A YU 23099A YU 23099 A YU23099 A YU 23099A YU 23099 A YU23099 A YU 23099A
Authority
YU
Yugoslavia
Prior art keywords
amphiphilic
ionic hydrophilic
sulphonyl
pharmaceutical compositions
compositions containing
Prior art date
Application number
YU23099A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of YU23099A publication Critical patent/YU23099A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
YU23099A 1996-12-05 1999-05-26 Pharmaceutical compositions containing n-sulphonyl indolin derivatives YU23099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
YU23099A true YU23099A (en) 1999-11-22

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
YU23099A YU23099A (en) 1996-12-05 1999-05-26 Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (sr)
JP (1) JP2000507618A (sr)
KR (1) KR20000069308A (sr)
CN (1) CN1239887A (sr)
AR (1) AR009651A1 (sr)
AU (1) AU716575B2 (sr)
BR (1) BR9712406A (sr)
CA (1) CA2273990A1 (sr)
CO (1) CO4910129A1 (sr)
DZ (1) DZ2362A1 (sr)
EE (1) EE9900206A (sr)
FR (1) FR2756736B1 (sr)
HU (1) HUP0001386A3 (sr)
ID (1) ID23373A (sr)
IL (1) IL129936A0 (sr)
IS (1) IS5062A (sr)
MY (1) MY132819A (sr)
NO (1) NO992724D0 (sr)
NZ (1) NZ335750A (sr)
RU (1) RU2174394C2 (sr)
SK (1) SK75599A3 (sr)
TR (1) TR199901702T2 (sr)
WO (1) WO1998024430A1 (sr)
YU (1) YU23099A (sr)
ZA (1) ZA9710919B (sr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
CA2359945C (en) 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
ID23373A (id) 2000-04-20
HUP0001386A3 (en) 2002-03-28
FR2756736A1 (fr) 1998-06-12
EP0941090A1 (fr) 1999-09-15
FR2756736B1 (fr) 1999-03-05
NO992724L (no) 1999-06-04
AU716575B2 (en) 2000-03-02
IS5062A (is) 1999-06-01
SK75599A3 (en) 2000-08-14
CA2273990A1 (fr) 1998-06-11
MY132819A (en) 2007-10-31
AR009651A1 (es) 2000-04-26
IL129936A0 (en) 2000-02-29
NZ335750A (en) 2001-06-29
ZA9710919B (en) 1999-06-04
HUP0001386A2 (hu) 2001-04-28
EE9900206A (et) 1999-12-15
CO4910129A1 (es) 2000-04-24
JP2000507618A (ja) 2000-06-20
KR20000069308A (ko) 2000-11-25
TR199901702T2 (en) 1999-09-21
WO1998024430A1 (fr) 1998-06-11
NO992724D0 (no) 1999-06-04
BR9712406A (pt) 1999-08-31
AU5326298A (en) 1998-06-29
DZ2362A1 (fr) 2002-12-28
CN1239887A (zh) 1999-12-29
RU2174394C2 (ru) 2001-10-10

Similar Documents

Publication Publication Date Title
YU23099A (en) Pharmaceutical compositions containing n-sulphonyl indolin derivatives
NO984790L (no) Midt-kjede forgrenede surfaktanter
DK0975235T3 (da) Ernæringssammensætninger indeholdende oligosaccharider
CA2316485A1 (en) Sustained-release pharmaceutical composition
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
DE3176125D1 (en) 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
TNSN97056A1 (fr) Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB2396813A (en) Sunscreen compositions
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
TR200101822T2 (tr) Kontrollü salınan galantamin bileşimi
BR9914698A (pt) Composto que se liga a um receptor mp1, dìmero, métodos para aumentar megacariócitos ou plaquetas em um paciente com necessidade disto, e para produzir um composto, composição farmacêutica, polinucleotìdeo, vetor, e, célula hospedeira.
TNSN97015A1 (fr) Nouveaux derives de 19-nor-pregnene.
WO1998023249A3 (en) Oral compositions containing fluoride, pyrophosphate, peroxide, and nonionic and/or amphoteric surfactants
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
BR9808396A (pt) Processo para aumentar a deposição de um agente benéfico de uma composição em barra, e, barra
ATE254478T1 (de) Stabile zusammensetzungen enthaltend ein retinoid und ein antioxidierendes system auf enzymbasis
FR2426731A1 (fr) Compositions tensio-actives aqueuses et concentrees
JP2000026260A (ja) 口腔用組成物
TNSN97156A1 (fr) Derives de pyrrolidinyl-et pyrrolinyl-ethylamine, procede pour leur preparation et compositions pharmaceutiques les contenant
BR9816072A (pt) Composição clareadora da pele contendo um composto de ácido ascórbico
IL104485A0 (en) Benzimidazoles,their preparation and pharmaceutical compositions containing them
AU2809697A (en) Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
EP0389079A3 (en) Polyamides bearing functionalized side chains useful as water soluble hypolipidemic agents
WO1999042092A3 (en) Compounds and methods of use for treatment of neurogenic inflammation